Rescue therapy with polymyxin B hemoperfusion in high-dose vasopressor therapy refractory septic shock

Minerva Anestesiologica

Volumn 81, Issue 5, 2015, Pages 516-525

  Monti, G ^a   Terzi, V ^a   Calini, A ^a   Di Marco, F ^b   Cruz, D ^c   Pulici, M ^a   Brioschi, P ^a   Vesconi, S ^a   Fumagalli, R ^d   Casella, G ^a  

^a OSPEDALE NIGUARDA CA GRANDA   (Italy)

^b UNIVERSITY OF MILAN   (Italy)

^c UNIVERSITY OF CALIFORNIA   (United States)

^d UNIVERSITY OF MILANO BICOCCA   (Italy)

Author keywords

Gram negative bacterial infections ; Hemoperfusion ; Multiple organ failure; Norepinephrine ; Septic ; Shock

Indexed keywords

ADRENALIN; HYPERTENSIVE FACTOR; LACTIC ACID; NORADRENALIN; POLYMYXIN B; VASOPRESSIN; ANTIINFECTIVE AGENT; EPINEPHRINE; VASOCONSTRICTOR AGENT;

ADULT; ARTICLE; BLOOD CULTURE; CENTRAL VENOUS PRESSURE; CONTINUOUS HEMOFILTRATION; DOSE RESPONSE; DRUG MEGADOSE; FEMALE; GRAM NEGATIVE INFECTION; HEMODYNAMICS; HEMOPERFUSION; HUMAN; INOTROPISM; KIDNEY FUNCTION; LACTATE BLOOD LEVEL; LENGTH OF STAY; LUNG FUNCTION; MAJOR CLINICAL STUDY; MALE; MEAN ARTERIAL PRESSURE; OBSERVATIONAL STUDY; OUTCOME ASSESSMENT; REFRACTORY SEPTIC SHOCK; RETROSPECTIVE STUDY; SEPTIC SHOCK; SIMPLIFIED ACUTE PHYSIOLOGY SCORE; TREATMENT OUTCOME; URINE VOLUME; AGED; DRUG RESISTANCE; HOSPITAL MORTALITY; MIDDLE AGED; MORTALITY; MULTIPLE ORGAN FAILURE; PATHOPHYSIOLOGY; SHOCK, SEPTIC;

ADULT; AGED; ANTI-BACTERIAL AGENTS; DRUG RESISTANCE; EPINEPHRINE; FEMALE; HEMOPERFUSION; HOSPITAL MORTALITY; HUMANS; MALE; MIDDLE AGED; MULTIPLE ORGAN FAILURE; NOREPINEPHRINE; POLYMYXIN B; RETROSPECTIVE STUDIES; SHOCK, SEPTIC; VASOCONSTRICTOR AGENTS;

EID: 84929747603     PISSN: 03759393     EISSN: 18271596     Source Type: Journal    
DOI: None     Document Type: Article

References (35)

1. Vincent JL, Sakr Y, Sprung CL, Ranieri VM, Reinhart K, Gerlach H et al. on behalf of the Sepsis Occurrence in Acutely Ill Patients Investigators. Sepsis in European intensive care units: Results of the SOAP study. Crit Care Med 2006;34:344-53.
2. Brown SM, Lanspa MJ, Jones JP, Kuttler KG, MStat YL, Carlson R et al. Survival after Shock Requiring High-Dose Vasopressor Therapy. Chest 2013;143:664-71.
3. Abe R, Oda S, Sadahiro T, Nakamura M, Hirayama Y, Tateishi Y et al. Gram-negative bacteremia induces greater magnitude of inflammatory response than Gram-positive bacteremia. Critical Care 2010;14:R27.
4. Annane D, Bellissant E, Cavaillon JM. Septic shock. Lancet 2005;365:63-78.
5. Rimmelé T, Kellum JA. Clinical review: blood purification for sepsis. Crit Care 2011;15:205.
6. Formica M, Olivieri C, Livigni S, Cesano G, Vallero A, Maio M et al. Hemodynamic response to coupled plasma-filtration-adsorption in human septic shock. Intensive Care Med 2003;29:703-8.
7. Honoré PM, Jamez J, Wauthier M, Lee PA, Dugernier T, Pirenne B et al. Prospective evaluation of short-term, high-volume isovolemic hemofiltration on the hemodynamic course and outcome in patients with intractable circulatory failure resulting from septic shock. Crit Care Med 2000;28:3581-7.
8. Joannes-Boyau O, Honoré PM, Perez P, Bagshaw SM, Grand H, Canivet JL et al. High-volume versus standard-volume haemofiltration for septic shock patients with acute kidney injury (IVOIRE study): a multicenter randomized controlled trial. Int Care Med 2013;39:1535-46.
9. Shoji H. Extracorporeal endotoxin removal for the treatment of sepsis: endotoxin adsorption cartridge (Toraymyxin). Ther Apher Dial 2003;7:108-14.
10. Uriu K, Osajima A, Kamochi M, Watanabe H, Aibara K, Kaizu K. Endotoxin removal by direct hemoperfusion with an adsorbent column using polymyxin b-immobilized fiber ameliorates systemic circulatory disturbance in patients with septic shock. Am J Kidney Dis 2002;39:937-47.
11. Ueno T, Sugino M, Nemoto H, Shoji H, Kakita A, Watanabe M. Effect over time of endotoxin adsorption therapy in sepsis. Ther Apher Dial 2005;9:128-36.
12. Cruz DN, Perazella MA, Bellomo R, de Cal M, Polanco N, Corradi V et al. Effectiveness of polymyxin B-immobilized fiber column in sepsis: a systemic review. Critical Care 2007;11:R47.
13. Cruz DN, Antonelli M, Fumagalli R, Foltran F, Brienza N, Donati A et al. Early use of polymyxin B hemoperfusion in abdominal septic shock. The EUPHAS Randomized Controlled Trial. JAMA 2009;301:2445-52.
14. Vincent JL, Nelson DR, Williams MD. In worsening multiple organ failure the cause of death in patients with severe sepsis?. Crit Care Med 2011;39:1050-5.
15. Dellinger RP, Carlet JM, Masur H, Gerlach H, Calandra T, Cohen J et al.; for the Surviving Sepsis Campaign Management Guidelines Committee. Surviving Sepsis Campaign guidelines for management of severe sepsis and septic shock. Crit Care Med 2004;32:858-73.
16. Dellinger RP, Levy MM, Carlet JM, Bion J, Parker MM, Jaeschke R et al.; for the International Surviving Sepsis Campaign Guidelines Committee. Surviving Sepsis Campaign: international guidelines for management of severe sepsis and septic shock: 2008. Crit Care Med 2008;36:296-327.
17. Dellinger RP, Levy MM, Rhodes A, Annane D, Gerlach H, Opal SM et al.; for the Surviving Sepsis Campaign Guidelines Committee including The Pediatric Subgroup. Surviving Sepsis Campaign: International Guidelines for Management of Severe Sepsis and Septic Shock, 2012. Intensive Care Med 2013;39:165-228.
18. Levy MM, Fink MP, Marshall JC, Abraham E, Angus D, Cook D et al.; for the International Sepsis Definitions Conference: SCCM/ESICM/ACCP/ATS/SIS International Sepsis Definitions Conference. Crit Care Med 2003;31:1250-6.
19. Vincent JL, de Mendonca A, Cantraine F, Moreno R, Takala J, Suter PM et al. Use of the SOFA score to assess the incidence of organ dysfunction/failure in intensive care units: results of a multicenter, prospective study. Working group on "sepsis-related problems" of the European Society of Intensive Care Medicine. Crit Care Med 1998;26:1793-800.
20. Bellomo R, Ronco C, Kellum JA, Mehta RL, Palevsky P. Acute renal failure-definition, outcome measures, animal models, fluid therapy and information technology needs: the Second International Consensus Conference of the Acute Dialysis Quality Initiative (ADQI) Group. Crit Care 2004;8:204-12.
21. Mitaka C, Tomita M. Polymyxin B immobilized fiber column hemoperfusion therapy for septic shock. Shock 2011;36:332-8.
22. Shore S, Nelson DP, Pearl JM, Manning PB, Wong H, Shanley TP et al. Usefulness of corticosteroid therapy in decreasing epinephrine requirements in critically ill infants with congenital heart disease. Am J Cardiol 2001;88:591-4.
23. Knaus WA, Draper EA, Wagner DP, Zimmerman JE. APACHE II: a severity of disease classification system. Crit Care Med 1985;13:818-29.
24. Le Gall JR, Lemeshow S, Saulnier F. A new Simplified Acute Physiology Score (SAPS II) based on a European/North American multicenter study. JAMA 1993;270:2957-63.
25. Vincent JL, Moreno R, Takala J, Willatts S, De Mendoca A, Bruining H et al. The SOFA (Sepsis-related Organ Failure Assessment) score to describe organ dysfunction/failure. On behalf of the Working Group on Sepsis-Related Problems of the European Society of Intensive Care Medicine. Intensive Care Med 1996;22:707-10.
26. Barrantes F, Tian J, Vazquez R, Amoateng-Adjepong Y, Manthous CA. Acute kidney injury criteria predict outcomes of critically ill patients. Crit Care Med 2008;36:1397-403.
27. Piccinni P, Dan M, Barbacini S, Carraro R, Lieta E, Marafon S et al. Early isovolaemic haemofiltration in oliguric patients with septic shock. Intensive Care Med 2006;32:80-6.
28. Benbenishty J, Weissman C, Sprung CL, Brodsky-Israeli M, Weiss Y. Characteristics of patients receiving vasopressors. Heart and Lung 2010;40:247-52.
29. Annane D, Vignan P, Renault A, Bollaert PE, Charpentier C, Martin C et al. for the CATS Study Group. Norepinephrine plus dobutamine versus epinephrine alone for management of septic shock: a randomized trial. Lancet 2007;370:676-84.
30. Kushi H, Miki T, Okamoto K, Nakahara J, Saito T, Tanjoh K. Early hemoperfusion with an immobilized polymyxin B fiber column eliminates humoral mediators and improves pulmonary oxygenation. Critical Care 2005;9:653-61.
31. Cantaluppi V, Assenzio B, Pasero D, Romanazzi GM, Pacitti A, Lanfranco G et al. Polymyxin-B hemoperfusion inactivates circulating proapoptotic factors. Intensive Care Med 2008;34:1638-45.
32. Mikkelsen ME, Miltiades AN, Gaieski DF, Goyal M, Fuchs BD, Shah CV et al. Serum lactate is associated with mortality in severe sepsis independent of organ failure and shock. Crit Care Med 2009;37:1670-7.
33. Bellomo R, Lipcsey M, Calzavacca P, Haase M, Haase-Fielitz A, Licari E et al. The RENAL Study Investigators and The ANZICS Clinical Trials Group. Early acid-base and blood pressure effects of continuous renal replacement therapy intensity in patients with metabolic acidosis. Intensive Care Med 2013;39:429-36.
34. Quenot JP, Binquet C, Kara F, Martinet O, Ganster F, Navellou JC et al for Episs study group. The epidemiology of septic shock in French intensive care units: the prospective multicenter cohort EPISS study. Crit Care 2013;17:R65.
35. Ranieri VM, Thompson BT, Barie PS, Dhainaut JF, Douglas IS, Finfer S et al.; PROWESS-SHOCK Study Group. Drotecogin Alfa (Activated) in adults with septic shock. NEJM 2012;366:2055-64.